Regulatory Announcement
The
Publication of Final Terms
The following Final Terms are available for viewing:
The
The following documents constitute the final terms dated
The Final Terms have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Final Terms have been filed with the Financial Conduct Authority and are available for viewing.
To view the CBL 70 Final Terms, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/2085L_1-2024-4-18.pdf
For further information, please contact:
Associate Vice President, Funding,
The
Telephone Number: +1 (416)-350-9434
Email: colin.elion@td.com
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Final Terms (when read together with the information in the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus and the Final Terms is not addressed. Prior to relying on the information contained in the Prospectus and the Final Terms you must ascertain from the Prospectus and the Final Terms whether or not you are an intended addressee of the information contained therein.
The Covered Bonds issued pursuant to the Prospectus and the related Covered Bond Guarantee (as defined in the Prospectus) have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within
Your right to access this service is conditional upon complying with the above requirements.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the